Co-Diagnostics, Inc. Common Stock (CODX) financials · rev $622.5K
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Co-Diagnostics, Inc. Common Stock (CODX) rev $622.5K.
| Line | FY2025 | FY2024 | Pro (2 older periods with Lician Pro) |
|---|---|---|---|
| Revenue | $622.49K | $3.92M | |
| Cost of Revenue | $222.38K | $999.12K | |
| Gross Profit | $400.11K | $2.92M | |
| Operating Income | −$50.17M | −$40.08M | |
| Net Income | −$46.90M | −$37.64M | |
| EPS (Diluted) | −$35.25 | −$1.24 | |
| Unlock 5 years of statements: Lician Pro $149/yr | |||
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Total Assets | $24.74M | $64.00M | |
| Current Assets | $13.69M | $32.29M | |
| Cash & Equivalents | $11.88M | $2.94M | |
| Inventory | $992.40K | $1.07M | |
| PP&E | $2.27M | $2.76M | |
| Total Liabilities | $4.11M | $9.69M | |
| Current Liabilities | $3.54M | $7.32M | |
| Shareholders' Equity | $20.63M | $54.31M | |
| Retained Earnings | −$80.37M | −$33.04M |
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Operating Cash Flow | −$29.14M | −$29.16M | |
| CapEx | $700.05K | $748.35K | |
| Investing Cash Flow | $26.27M | $17.07M | |
| Financing Cash Flow | $11.81M | $103.91K | |
| Net Change in Cash | $8.95M | −$11.98M | |
| Free Cash Flow | −$29.84M | −$29.90M |
Source: Company filings with the SEC (EDGAR) · Latest period FY2025
FAQ
What is CODX P/E and revenue?
Co-Diagnostics, Inc. Common Stock (CODX) rev $622.5K.
What is CODX revenue?
Co-Diagnostics, Inc. Common Stock last cached revenue is $622.5K (FY2025).
Is CODX profitable?
Co-Diagnostics, Inc. Common Stock last cached net income is -$46.9M (FY2025).
What are CODX total assets?
Co-Diagnostics, Inc. Common Stock last cached total assets are $24.7M (FY2025).
What is CODX free cash flow?
Co-Diagnostics, Inc. Common Stock last cached free cash flow is -$29.8M (FY2025).
Not investment advice. Figures as reported in company filings, not a live feed.